Status:
COMPLETED
Inflammation and Organ Impact During Hepatic Surgery
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Hepatic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Monitoring of inflammatory substances (such as interleukins, CRP, albumine), and markers of organ dysfunction (such as creatinine, proenkephaline, amylase, troponine, IFABP and lactate) during electiv...
Detailed Description
During hepatic surgery, blood and urine samples will be obtained at 3 times during surgery, at 3 h after resection of liver, at 24 h after resection of liver and at post operative day 2, and subsequnt...
Eligibility Criteria
Inclusion
- ASA I-III Patient has given informed consent to participate in study.
Exclusion
- preoperative kidney failure (E-GFR \>30), current infection treatment with corticosteroids coagulopathy surgical or anatomical conditions that makes patient unsuitable for participation (for example reoperation, need of vascular bypass, single tumor)
Key Trial Info
Start Date :
November 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03878615
Start Date
November 10 2018
End Date
April 2 2019
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SahlgrenskaUH
Gothenburg, Västra Götaland County, Sweden, 41345